Research & News
PrEP in Clinical Setting Results in No New HIV Infections
Dec 30, 2015
In a large clinical practice setting, there has been an increasing amount of referrals and initiation of preexposure prophylaxis (PrEP) for the prevention of HIV transmission. In this particular group over a three year period, there were no new cases of HIV among those... Read More
HIV Medications and Hormonal Contraceptives
Dec 30, 2015
The Partners in Prevention HSVHIV Transmission Study and Partners in PrEP Study researchers looked at the effectiveness of hormonal contraceptives in preventing pregnancy for those women on antiretroviral therapy. They found that ART did not significantly diminish the... Read More
Do Financial Incentives Increase HIV Care Engagement and Retention?
Oct 23, 2015
Successful HIV care involves getting tested, initiating care, remaining in care, and taking ARVs as needed. Movement through the HIV care cascade may be helped by the use of financial incentives that reward patients for completing steps in the cascade. Researchers... Read More
Prevention of Perinatal HIV Case Review
Oct 23, 2015
Researchers in Georgia completed a case review of HIV-infected infants born between 2005-2012 for risk factors associated with mother-to-child transmission of HIV. Of the 27 cases identified, 53% of mothers did not receive ARVs during pregnancy or labor. Additionally,... Read More
WHO Guidelines on PrEP and Initiation of ARVs for HIV
Sep 15, 2015
The World Health Organization released its Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV as a early release in preparation for updating its guidelines on the use of antiretroviral therapy for treating and preventing HIV which is... Read More
Hormonal Contraception and Interactions with ARVs
Sep 01, 2015
Publications and pharmaceutical packages were reviewed to determine any contraindications for ARV co-administration with hormonal contraceptive methods (oral contraceptive pills, injectable dept medroxyprogesterone acetate [DMPA], levonorgestrel intrauterine system [LNG-... Read More
Updated Perinatal Guidelines Now Available
Aug 13, 2015
The HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission announced the release of the updated Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce... Read More
HIV Viral Load During Pregnancy Impacted by Time of Diagnosis and Prenatal Care
Jul 28, 2015
A retrospective review of HIV-positive women who delivered in Philadelphia between 2005-2013 found that women who were diagnosed HIV-positive during pregnancy were less likely to receive antiretroviral therapy and have an undetectable viral load than those diagnosed prior... Read More
FDA Approves Test to Distinguish Type of HIV Infection
Jul 28, 2015
The BioPlex 2200 HIV Ag-Ab assay has been approved by the FDA for use in distinguishing between HIV-1 antibodies, HIV-2 antibodies and the HIV-1 p24 antigen.This is approved for use in pregnant women and is another tool to aid in prevention of perinatal transmission... Read More
HIV Remission for Perinatally Infected Patient
Jul 28, 2015
A presentation at this year's International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention shared data on a patient who was diagnosed HIV-positive at 4 weeks of age, started on ART at 3 months of age (with a high viral load), and achieved an... Read More
